Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.41
Oct. 07, 2025 16:00:00- Change 0.0457 (12.68387%)
- Volume 7,602,559
- Today's Open 0.365
- Previous Close 0.3603
- Today's High 0.415
- Today's Low 0.3598
- 52 Week High 4.3
- 52 Week Low 0.281